Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.11
-0.19 (-3.58%)
Apr 29, 2026, 10:48 AM EDT - Market open
Zura Bio Employees
Zura Bio had 40 employees as of December 31, 2025. The number of employees increased by 10 or 33.33% compared to the previous year.
Employees
40
Change (1Y)
10
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,483,825
Market Cap
484.84M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 40 | 10 | 33.33% | 40 | 0 |
| Dec 31, 2024 | 30 | 15 | 100.00% | 30 | 0 |
| Dec 31, 2023 | 15 | - | - | 14 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Lyell Immunopharma | 300 |
| ADC Therapeutics | 193 |
| Verastem | 102 |
| enGene Therapeutics | 82 |
| Upstream Bio | 75 |
| Tectonic Therapeutic | 60 |
| AgomAb Therapeutics NV | 58 |
ZURA News
- 5 weeks ago - Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates - Business Wire
- 7 weeks ago - Zura Bio Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress - Business Wire
- 2 months ago - Zura Bio to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Business Wire
- 2 months ago - Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants - Business Wire
- 2 months ago - Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants - Business Wire
- 2 months ago - Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D. - Business Wire